As of Apr 20
| +0.39 / +1.95%|
The 5 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 23.00 and a low estimate of 13.00. The median estimate represents a -11.72% decrease from the last price of 20.39.
The current consensus among 5 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.